World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN92166461
Date of registration: 23/01/2004
Prospective Registration: No
Primary sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Public title: Assessment of anticoagulant control in primary care using near patient testing and computerised decision support.
Scientific title:
Date of first enrolment: 01/10/1994
Target sample size: 368
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN92166461
Study type:  Interventional
Study design:  Randomised controlled trial (Other)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: FDR    Hobbs
Address:  The Department of Primary Care and General Practice Medical School University of Birmingham Edgbaston B15 2TT Birmingham United Kingdom
Telephone: +44 (0)121 414 3765
Email: f.d.r.hobbs@bham.ac.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients receiving warfarin therapy (n=368)
Exclusion criteria: Does not meet inclusion criteria

Age minimum:
Age maximum:
Gender: Not Specified
Health Condition(s) or Problem(s) studied
Thromboembolic disease
Circulatory System
Arterial embolism and thrombosis
Intervention(s)
A randomised controlled trial using 12 primary care practices in Birmingham, UK (9 intervention and 3 control). The study used 2 control populations; patients individually randomly allocated as controls in the intervention practices (intra-practice controls), and all patients in the 3 control practices (inter-practice controls), included to estimate any Hawthorne effect amongst the intervention controls. Patients from the 9 intervention practices were randomised to intervention (practice based anticoagulation clinic) or control (traditional attendance at hospital clinic).
Primary Outcome(s)
The main outcome measure used was INR control determined by; number of tests performed within target INR range; point prevalence of patients achieving individual therapeutic INR targets; and individual proportion of time spent within therapeutic target range.
Secondary Outcome(s)
Not provided at time of registration
Secondary ID(s)
PSI03-08
Source(s) of Monetary Support
NHS Primary and Secondary Care Interface National Research and Development Programme (UK)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history